The A1/A1 genotype of the anti-inflammatory cytokine interleukin 1 receptor
antagonist (IL-1Ra) polymorphism was more frequent in 339 Italian MS,patie
nts than in healthy controls (HCs) (odds ratio = 1.83). A more aggressive d
isease course was also associated with A1(+) genotypes and might reflect th
e reduced ability of mononuclear cell cultures of A1(+) HCs to produce IL-1
Ra. We conclude that an IL-1Ra gene polymorphism is associated with occurre
nce of;disease and clinical course variability in Italian MS patients.